Keywords: enzon, enrolls, first, patient, ph, hif-1, alpha

Enzon enrolls first patient in Ph I HIF-1 alpha antagonist study

Article | 09 April 2007

Print This

New Jersey, USA-based Enzon Pharmaceuticals has enrolled the first patient in its Phase I clinical study of the HIF-1 alpha ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in